Advanced Biomed Inc. (the “Company” or “Advanced Biomed”), a biotechnology company focused on early screening and detection, ...

Advanced Biomed Inc. completes IPO of 1.64 million shares, raising $6.56 million for cancer diagnostic advancements. Advanced Biomed Inc., a biotechnology company specializing in cancer detection ...

Advanced Biomed Inc. (ADVB) expects to raise $10 million in an initial public offering (IPO) on the week of February 24th, IPO Scoop reports. The company will be issuing 1,900,000 shares at $4.00 ...

This week, Advanced Biomed (ADVB) is looking to raise $112M under its initial public offering. The company is developing a portfolio of cancer screening technologies for the Chinese market.

Craft Capital Management LLC acted as underwriter for the Offering (the “Underwriter”). VCL Law LLP acted as U.S. securities counsel to the Company, and Ortoli Rosenstadt LLP acted as U.S. securities ...

Tainan, Taiwan, March 06, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the “Company” or “Advanced Biomed”), a biotechnology company focused on early screening and detection, diagnosis ...